The use of fibrin glue in surgery of the knee

Journal of Bone and Joint Surgery - Series B

Volumn 92, Issue 10, 2010, Pages 1325-1331

  Patel, S ^a   Rodriguez Merchan, E C ^a,b   Haddad, F S ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 13; FIBRIN GLUE; FIBRIN MONOMER; FIBRINOGEN; THROMBIN; TRANEXAMIC ACID;

ALLERGIC REACTION; ANAPHYLAXIS; ANTERIOR CRUCIATE LIGAMENT RUPTURE; ARTICULAR CARTILAGE; BENIGN TUMOR; CARTILAGE INJURY; CRYOPRECIPITATION; DISEASE PREDISPOSITION; DRUG SAFETY; FATALITY; FIBRIN CLOT; HUMAN; HUMAN PARVOVIRUS B19; INFECTION RISK; KNEE MENISCUS RUPTURE; KNEE SURGERY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; THERMOSTABILITY; TOTAL KNEE REPLACEMENT; VIRUS TRANSMISSION;

ANIMALS; ARTHROPLASTY, REPLACEMENT, KNEE; FIBRIN TISSUE ADHESIVE; HEMOSTASIS, SURGICAL; HUMANS; KNEE INJURIES; KNEE JOINT; TISSUE ADHESIVES;

EID: 77957835878     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.92B10.24828     Document Type: Review

References (82)

1. Bergel S. Über Wirkung des Fibrins. Dtsch Med Wochenschr 1909;35:663-5 (in German).
2. Grey EG. Fibrin as a haemostatic in cerebral surgery. Surg Gynecol Obstet 1915;21:452-4.
3. Harvey SC. The use of fibrin paper and forms in surgery. Boston Med Surg J 1916;174:658-9.
4. Young JZ, Medawar PB. Fibrin suture of peripheral nerves. Lancet 1940;236:126-8.
5. Tarlov IM, Benjamin B. Plasma clot and slk suture of nerves. Surg Gynecol Obstet 1943;76:367-74.
6. Cronkite EP, Lozner EL, Deaver JM. Use of thrombin and fibrinogen in skin grafting. JAMA 1944;124:976-8.
7. Matras H. Fibrin seal: the state of the art. J Oral Maxillofac Surg 1985;43:605-11.
8. Sierra DH. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J Biomater Appl 1993;7:309-52.
9. Matras H, Dinges HP, Lassmann H, Mamoli B. Suture-free interfascicular nerve transplantation in animal experiments. Wien Med Wochenschr 1972;122:517-23 (in German).
10. Kuderna H, Matras H. The clinical use of the splice of nerve anastamosis in the reconstruction of more injured peripheral nerves. Wien Klin Wochenschr 1975;87:495-6 (in German).
11. Fattahi T, Mohan M, Caldwell GT. Clinical applications of fibrin sealants. J Oral Maxillofac Surg 2004;62:218-24.
12. Durham LH, Willatt DJ, Yung MW, et al. A method for preparation of fibrin glue. J Laryngol Otol 1987;101:1182-6.
13. Oz MC, Jeevanandam V, Smith CR, et al. Autologous fibrin glue from intraoperatively collected platelet-rich plasma. Ann Thorac Surg 1992;53:530-1.
14. Alston SM, Solen KA, Broderick AH, Sukavaneshvar S, Mohammad SF. New method to prepare autologous fibrin glue on demand. Transl Res 2007;149:187-95. (Pubitemid 46442007)
15. Jackson MR, MacPhee MJ, Drohan WN, Alving BM. Fibrin sealant: current and potential clinical applications. Blood Coagul Fibrinolysis 1996;7:737-46.
16. Tredree R, Beierlein W, Debrix I, et al. Evaluating the differences between fibrin sealants: recommendations from an international advisory panel of hospital pharmacists. Eur J Hosp Pharm Sci 2006;12:3-9.
17. Kjaergard HK, Trumbull HR. Vivostat system autologous fibrin sealant: preliminary study in elective coronary bypass grafting. Ann Thorac Surg 1998;66:482-6.
18. Oswald AM, Joly LM, Gury C, et al. Fatal intraoperative anaphylaxis related to aprotinin after local application of fibrin glue. Anesthesiology 2003;99:762-3. (Pubitemid 37052003)
19. Schievink WI, Geoganos SA, Maya MM, Moser FG, Bladyka M. Anaphylactic reactions to fibrin sealant injection for spontaneous spinal CSF leaks. Neurology 2008;70:885-7. (Pubitemid 351367517)
20. Kon NF, Masumo H, Nakajima S, et al. Anaphylactic reaction to aprotinin following topical use of biological tissue sealant. Masui 1994;43:1606-10 (in Japanese). (Pubitemid 24353678)
21. Shirai T, Shimota H, Chida K, et al. Anaphylaxis to aprotinin in fibrin sealant. Intern Med 2005;44:1088-9.
22. Scheule AM, Beierlein W, Lorenz H, Ziemer G. Repeated anaphylactic reactions to aprotinin in fibrin sealant. Gastrointest Endosc 1998;48:83-5. (Pubitemid 28337438)
23. Beierlein W, Scheule AM, Antoniades G, Braun C, Schosser R. An immediate, allergic skin reaction to aprotinin after reexposure to fibrin sealant. Transfusion 2000;40:302-5. (Pubitemid 30171679)
24. Dietrich W, Späth P, Ebell A, Richter JA. Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 1997;113:194-201. (Pubitemid 27034358)
25. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 2008;358:771-83. (Pubitemid 351284455)
26. Lew WK, Weaver FA. Clinical use of topical thrombin as a surgical hemostat. Biologics 2008;2:593-9.
27. No authors listed. Quixil human surgical sealant: update on fatal neurotoxic reactions. Current Problems in Pharmacovigilance 2000;6:10.
28. Hino M, Yamamura R, Nishiki S, et al. Human parvovirus B19-induced aplastic crisis in a patient treated with fibrin sealant. Rinsho Ketsueki 1999;108:145-9.
29. Hino M, Ishiko O, Honda KI, et al. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol 2000;108:194-5. (Pubitemid 30089954)
30. Morita Y, Nishii O, Kido M, Tsutsumi O. Parvovirus infection after laparoscopic hysterectomy using fibrin glue hemostasis. Obstet Gynecol 2000;95:1026. (Pubitemid 30251947)
31. Honda K, Ishiko O, Tsujimura A, et al. Neutropenia accompanying parvovirus B19 infection after gynecologic surgery. Acta Haematol 2000;103:186-90.
32. Enoki C, Higashi S, Oohata M, Tanaka T. A case of acute erythroblastic anemia due to infection with human parvovirus B19 after coronary artery bypass grafting. Kyobu Geka 2002;55:116-19 (in Japanese).
33. Kawamura M, Sawafuji M, Watanabe M, Horinouchi H, Kobayashi K. Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann Thorac Surg 2002;73:1098-100. (Pubitemid 34275886)
34. Tournoux F, Karila-Cohen D, Hvass U, et al. Neutropenia and fever after aortocoronary bypasses. Ann Chir 2004;129:174-6 (in French).
35. Wilson SM, Pell P, Donegan EA. HIV-1 transmission following the use of cryoprecipitated fibrinogen as gel/adhesive. Transfusion 1991;31(Suppl):51.
36. Horowitz B, Busch M. Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin. Transfusion 2008;48:1739-53.
37. Sehat KR, Evans R, Newman JH. How much blood is really lost in total knee arthroplasty: correct blood loss management should take hidden loss into account. Knee 2000;7:151-5. (Pubitemid 30601705)
38. Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty: correct management of blood loss should take hidden loss into account. J Bone Joint Surg [Br] 2004;86-B:561-5.
39. Hynes M, Calder P, Scott G. The use of tranexamic acid to reduce blood loss during total knee arthroplasty. Knee 2003;10:375-7. (Pubitemid 37415224)
40. Ralley FE, Berta D, Binns V, Howard J, Naudie DD. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop 2010:Epub.
41. Lombardi AV Jr, Berend KR, Mallory TH, Dodds KL, Adams JB. Soft tissue and intra-articular injection of bupivacaine, epinephrine, and morphine has a beneficial effect after total knee arthroplasty. Clin Orthop 2004;428:125-30.
42. Anderson LA, Engel GM, Bruckner JD, Stoddard GJ, Peters CL. Reduced blood loss after total knee arthroplasty with local injection of bupivacaine and epinephrine. J Knee Surg 2009;22:130-6.
43. Tsumara N, Yoshiya S, Chin T, et al. A prospective comparison of clamping the drain or post-operative salvage of blood in reducing blood loss after total knee arthroplasty. J Bone Joint Surg [Br] 2006;88-B:49-53. (Pubitemid 43125313)
44. Roy N, Smith M, Anward M, Elsworth C. Delayed release of drain in total knee replacement reduces blood loss: a prospective randomised study. Acta Orthop Belg 2006;72:34-8.
45. Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 2003;90:596-9. (Pubitemid 36592332)
46. Malone KJ, Matuszak S, Mayo D, Greene P. The effect of intra-articular epine-prine lavage on blood loss following total knee arthroplasty. Orthopedics 2009;32:100.
47. Tai TW, Yang CY, Jou IM, Lai KA, Chen CH. Temporary drainage clamping after total knee arthroplasty: a meta-analysis of randomized controlled trials. J Arthroplasty 2009:Epub.
48. Akizuki S, Yasukawa Y, Takizawa T. A new method of hemostasis for cementless total knee arthroplasty. Bull Hosp Jt Dis 1997;56:222-4. (Pubitemid 28070568)
49. Curtin WA, Wang GJ, Goodman NC, Abbott RD, Spotnitz WD. Reduction of hemorrhage after knee arthroplasty using cryo-based fibrin sealant. J Arthroplasty 1999;14:481-7.
50. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty: a prospective, randomized, multicenter study. J Bone Joint Surg [Am] 1999;81-A:1580-8.
51. Wang GJ, Hungerford DS, Savory CG, et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg [Am] 2001;83-A:1503-5.
52. Wang GJ, Goldthwaite CA Jr, Burks SG, Spotnitz WD; Orthopaedic Research Group. Experience improves successful use of fibrin sealant in total knee arthroplasty: implications for surgical education. J Long Term Eff Med Implants 2003;13:389-97.
53. Molloy DO, Archbold HA, Ogondo L, et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg [Br] 2007;89-B:306-9.
54. Gardner MJ, Demetrakopoulos D, Klepchick PR, Mooar PA. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty: an analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop 2007;31:309-13. (Pubitemid 46800749)
55. Everts PA, Devilee RJ, Oosterbos CJ, et al. Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surg Sports Traumatol Arthrosc 2007;15:888-94.
56. Everts PA, Devilee RJ, Brown Mahoney C, et al. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand 2006;50:593-9.
57. Cohen I, Heim M, Martinowitz U, Chechick A. Orthopaedic outcome of total knee replaceent in haemophilia A. Haemophilia 2000;6:104-9. (Pubitemid 30166832)
58. Kaplonyi G, Zimmerman I, Frenyo AD, Farkas T, Nemes G. The use of fibrin adhesive in the repair of chondral and osteochondral injuries. Injury 1988;19:267-72.
59. Plaga BR, Royster RM, Donigian AM, Wright GB, Caskey PM. Fixation of osteochondral fractures in rabbit knees: a comparison of Kirschner wires, fibrin sealant, and polydioxanone pins. J Bone Joint Surg [Br] 1992;74-B:292-6.
60. Ronga M, Grassi FA, Bulgheroni P. Arthroscopic autologous chondrocyte implantation for the treatment of a chondral defect in the tibial plateau of the knee. Arthroscopy 2004;20:79-84. (Pubitemid 38063894)
61. Zilch H, Wolff R. Fibrin glue and bone regeneration. Z Orthop Ihre Grenzgeb 1987;125:214-18 (in German).
62. Schwarz N, Redl H, Zeng L, et al. Early osteoinduction in rats is not altered by fibrin sealant. Clin Orthop 1993;293:353-9. (Pubitemid 23242891)
63. Schwarz N. The role of fibrin sealant in osteoinduction. Ann Chir Gynaecol Suppl 1993;207:63-8.
64. Kiriak Y, Pavlos NJ, Willers CR, et al. Fibrin sealant promotes migration and proliferation of human articular chondrocytes: possible involvement of thrombin and protease- activated receptors. Int J Mol Med 2006;17:551-8.
65. Kim MK, Choi SW, Kim SR, Oh IS, Won MH. Autologous chondrocyte implantation in the knee using fibrin. Knee Surg Sports Traumatol Arthrosc 2010;18:528-34.
66. Biswal S, Hastie T, Andriacchi TP, et al. Risk factors for progressive cartilage loss in the knee: a longitudinal magnetic resonance imaging study in forty-three patients. Arthritis Rheum 2002;46:2884-92. (Pubitemid 35315879)
67. Ishimura M, Ohgushi H, Habata T, Tamai S, Fujisawa Y. Arthroscopic meniscal repair using fibrin glue. Part II: clinical applications. Arthroscopy 1997;13:558-63.
68. Roeddecker K, Nagelschmidt M, Koebke J, Guensche K. Meniscal healing: a histological study in rabbits. Knee Surg Sports Traumatol Arthrosc 1993;1:28-33.
69. Ishimura M, Ohgushi H, Habata T, Tamai S, Fujisawa Y. Arthroscopic meniscal repair using fibrin glue. Part I: experimental study. Arthroscopy 1997;13:551-7.
70. Izuta Y, Ochi M, Adachi N, et al. Meniscal repair using bone marrow-derived mesenchymal stem cells: experimental study using green fluorescent protein transgenic rats. Knee 2005;12:217-23. (Pubitemid 40720230)
71. Hashimoto J, Kurosaka M, Yoshiya S, Hirohata K. Meniscal repair using fibrin sealant and endothelial cell growth factor: an experimental study in dogs. Am J Sports Med 1992;20:537-41.
72. Scotti C, Pozzi A, Mangiavini L, et al. Healing of meniscal tissue by cellular fibrin glue: an in vivo study. Knee Surg Sports Traumatol Arthrosc 2009;17:645-51.
73. Paar O. Reinforcement of freshly glued or sutured rupture of the anterior cruciate ligament using the semitendinous tendon: indications and early results. Chirurg 1985;56:728-34 (in German).
74. Aubart F, Roger B, Zeine G. Repair by glueing under arthroscopic control of ruptures of the anterior cruciate ligament: preliminary study of 10 cases controlled by magnetic resonance imaging. Rev Chir Orthop Reparatrice Appar Mot 1991;77:267-72 (in French).
75. Lazovic D, Messner K. Collagen repair not improved by fibrin adhesive: cruciate ligament ruptures studied in dogs. Acta Orthop Scand 1993;64:583-6. (Pubitemid 23329871)
76. Goodman SB, Song Y, Chun L, Regula D, Aspenberg P. Effects of TGFbeta on bone ingrowth in the presence of polyethylene particles. J Bone Joint Surg [Br] 1999;81-B:1069-75.
77. Csaki C, Schneider PR, Shakibaei M. Mesenchymal stem cells as a potential pool for cartilage tissue engineering. Ann Anat 2008;190:395-412.
78. Yamazaki S, Yasuda K, Tomita F, Tohyama H, Minami A. The effect of transforming growth factor-beta1 on intraosseous healing of flexor tendon autograft replacement of anterior cruciate ligament in dogs. Arthroscopy 2005;21:1034-41. (Pubitemid 41323866)
79. Lim JK, Hui J, Li L, et al. Enhancement of tendon graft osteointegration using mesenchymal stem cells in a rabbit model of anterior cruciate ligament reconstruction. Arthroscopy 2004;20:899-910. (Pubitemid 39452262)
80. Soon MY, Hassan A, Hui JH, Goh JC, Lee EH. An analysis of soft tissue allograft anterior cruciate ligament reconstruction in a rabbit model: a short-term study of the use of mesenchymal stem cells to enhance tendon osteointegration. Am J Sports Med 2007;35:962-71. (Pubitemid 46956291)
81. Rodriguez-Merchan EC. The haemophilic pseudotumour. Int Orthop 1995;19:255-60.
82. Mifsut D, Llorente MJ, Sanchez F. Unusual synovial cyst of the knee treatment with fibrin sealant. J Rheumatol 2001;28:2763-4.